HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis

NYSE:HIMS • US4330001060

15.84 USD
-0.43 (-2.64%)
At close: Feb 18, 2026
15.88 USD
+0.04 (+0.25%)
After Hours: 2/18/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, HIMS scores 5 out of 10 in our fundamental rating. HIMS was compared to 102 industry peers in the Health Care Providers & Services industry. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation. HIMS is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year HIMS was profitable.
  • HIMS had a positive operating cash flow in the past year.
  • In the past 5 years HIMS reported 4 times negative net income.
  • In multiple years HIMS reported negative operating cash flow during the last 5 years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of HIMS (5.99%) is better than 81.37% of its industry peers.
  • HIMS has a Return On Equity of 23.03%. This is amongst the best in the industry. HIMS outperforms 90.20% of its industry peers.
  • HIMS has a better Return On Invested Capital (5.84%) than 62.75% of its industry peers.
Industry RankSector Rank
ROA 5.99%
ROE 23.03%
ROIC 5.84%
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

  • HIMS's Profit Margin of 6.05% is amongst the best of the industry. HIMS outperforms 81.37% of its industry peers.
  • Looking at the Operating Margin, with a value of 5.96%, HIMS is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
  • HIMS has a Gross Margin of 75.01%. This is amongst the best in the industry. HIMS outperforms 90.20% of its industry peers.
  • HIMS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.96%
PM (TTM) 6.05%
GM 75.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
  • HIMS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, HIMS has more shares outstanding
  • There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.66 indicates that HIMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of HIMS (2.66) is comparable to the rest of the industry.
  • HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
  • HIMS has a Debt to FCF ratio of 8.13. This is comparable to the rest of the industry: HIMS outperforms 50.98% of its industry peers.
  • A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
  • The Debt to Equity ratio of HIMS (1.67) is worse than 69.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 8.13
Altman-Z 2.66
ROIC/WACC0.67
WACC8.69%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
  • HIMS's Current ratio of 1.88 is fine compared to the rest of the industry. HIMS outperforms 77.45% of its industry peers.
  • HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.64
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 22.73% over the past year.
  • The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
  • The Revenue has grown by 78.02% in the past year. This is a very strong growth!
  • Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%

3.2 Future

  • HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.57% yearly.
  • The Revenue is expected to grow by 22.80% on average over the next years. This is a very strong growth
EPS Next Y-11.37%
EPS Next 2Y3.76%
EPS Next 3Y13.74%
EPS Next 5Y28.57%
Revenue Next Year60.27%
Revenue Next 2Y37.46%
Revenue Next 3Y30.81%
Revenue Next 5Y22.8%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • HIMS is valuated quite expensively with a Price/Earnings ratio of 29.33.
  • HIMS's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of HIMS to the average of the S&P500 Index (27.27), we can say HIMS is valued inline with the index average.
  • A Price/Forward Earnings ratio of 27.24 indicates a quite expensive valuation of HIMS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
  • HIMS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.33
Fwd PE 27.24
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 30.18
EV/EBITDA 21.58
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The decent profitability rating of HIMS may justify a higher PE ratio.
  • HIMS's earnings are expected to grow with 13.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2Y3.76%
EPS Next 3Y13.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HIMS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIMS & HERS HEALTH INC

NYSE:HIMS (2/18/2026, 8:04:00 PM)

After market: 15.88 +0.04 (+0.25%)

15.84

-0.43 (-2.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-03
Earnings (Next)02-23
Inst Owners94.2%
Inst Owner Change-5.43%
Ins Owners5.93%
Ins Owner Change-1.41%
Market Cap3.61B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.27
Price Target43.45 (174.31%)
Short Float %37.45%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-6.36%
PT rev (3m)-12.76%
EPS NQ rev (1m)15.33%
EPS NQ rev (3m)-50.63%
EPS NY rev (1m)1.4%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 29.33
Fwd PE 27.24
P/S 1.63
P/FCF 30.18
P/OCF 11.09
P/B 6.21
P/tB 28.43
EV/EBITDA 21.58
EPS(TTM)0.54
EY3.41%
EPS(NY)0.58
Fwd EY3.67%
FCF(TTM)0.52
FCFY3.31%
OCF(TTM)1.43
OCFY9.02%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)0.49
Graham Number5.57
Profitability
Industry RankSector Rank
ROA 5.99%
ROE 23.03%
ROCE 7.39%
ROIC 5.84%
ROICexc 9.03%
ROICexgc 14.91%
OM 5.96%
PM (TTM) 6.05%
GM 75.01%
FCFM 5.4%
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 8.13
Debt/EBITDA 5.57
Cap/Depr 484.08%
Cap/Sales 9.3%
Interest Coverage 250
Cash Conversion 186.53%
Profit Quality 89.31%
Current Ratio 1.88
Quick Ratio 1.64
Altman-Z 2.66
F-Score3
WACC8.69%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-11.37%
EPS Next 2Y3.76%
EPS Next 3Y13.74%
EPS Next 5Y28.57%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.46%
Revenue Next 3Y30.81%
Revenue Next 5Y22.8%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.58%
EBIT Next 3Y89.54%
EBIT Next 5Y57.83%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A

HIMS & HERS HEALTH INC / HIMS FAQ

What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HIMS.


What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a valuation rating of 3 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.


What is the profitability of HIMS stock?

HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.


What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?

The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.